PTH and Bone: A Complete Overview

1. PTH - Quick Background

2. Effects of PTH on Blood Calcium and Phosphate

3. How PTH Mobilizes Calcium from Bone

Phase 1 - Rapid Osteolysis (Minutes to Hours)

• PTH binds receptors on osteoblasts and osteocytes, activating the osteocytic membrane calcium pump
• The osteocytic membrane system is a network of interconnected cells spanning the entire bone, separated from extracellular fluid by a membrane layer
• Normally, bone fluid calcium is only ~1/3 of extracellular fluid calcium - PTH drives the pump harder, pulling calcium phosphate out of amorphous bone crystals into extracellular fluid
• This process - osteolysis - occurs without destroying the bone's fibrous/gel matrix
• Blood calcium begins rising within minutes of PTH exposure

"PTH activates the calcium pump strongly, thereby causing rapid removal of calcium phosphate salts from the amorphous bone crystals that lie near the cells."

• Guyton and Hall Textbook of Medical Physiology, p. 989

Phase 2 - Slow Osteoclastic Resorption (Days to Weeks)

• PTH stimulates osteoblasts/osteocytes to produce RANKL (Receptor Activator of NF-kB Ligand)
• RANKL binds RANK receptors on osteoclast precursors, driving their differentiation into mature, active osteoclasts
• PTH also reduces OPG (osteoprotegerin) production by osteoblasts - OPG is the decoy protein that normally blocks RANKL-RANK binding
• This slow phase takes several days to develop fully and leads to actual bone resorption (destruction of collagen matrix + mineral)
• After months of excess PTH, osteoclastic resorption dominates, and bones can develop large cavities filled with multinucleated osteoclasts

4. The RANKL/OPG/RANK Axis (Key Molecular Mechanism)

"PTH acts on the osteoblast to induce membrane-bound and secreted soluble forms of a protein called RANK (RANKL). RANKL acts on osteoclasts and osteoclast precursors to increase both the numbers and activity of osteoclasts."

• Katzung's Basic and Clinical Pharmacology, 16th Ed., p. 1211

5. PTH and Sclerostin Inhibition

• The Wnt pathway is disinhibited
• Osteoblast proliferation and bone formation is enhanced
• This is part of the anabolic mechanism of PTH

6. Intermittent vs. Continuous PTH - The Anabolic vs. Catabolic Paradox

"Brief or intermittent treatment with PTH is anabolic; it stimulates bone deposition through cAMP/IGF-1 pathways in osteocytes and osteoblasts. Conversely, prolonged and continuous treatment is catabolic; it increases production of RANKL molecules by osteoblasts and T lymphocytes."

• Histology: A Text and Atlas with Correlated Cell and Molecular Biology

7. Bone as a Calcium Buffer

• Short-term calcium deficit → PTH rapidly pulls calcium from exchangeable amorphous bone crystals
• Prolonged deficit (months to years) → osteoclastic resorption provides sustained calcium release
• If this continues too long (e.g., dietary calcium deficiency), bones eventually become depleted

"In effect, the bones provide a large buffer-reservoir of calcium that can be manipulated by PTH."

• Guyton and Hall Textbook of Medical Physiology, p. 991

8. Pathological States

Hypoparathyroidism

• Osteocytic resorption decreases, osteoclasts become nearly inactive
• Serum calcium falls (can drop from 9.4 to 6-7 mg/dL in 2-3 days after parathyroidectomy)
• Bones paradoxically remain strong (no excess resorption)
• Clinically: tetany, laryngospasm, risk of death from respiratory obstruction

Primary Hyperparathyroidism

• Usually caused by a parathyroid adenoma
• Prolonged PTH excess → massive osteoclast activation → bones become weak, develop large cavities
• Serum calcium elevated; phosphate low
• Classic bone finding: osteitis fibrosa cystica (brown tumors, "salt and pepper" skull on X-ray)

Secondary Hyperparathyroidism (Chronic Kidney Disease)

• Low 1,25(OH)2D + phosphate retention → reduced calcium → elevated PTH
• Continuous PTH stimulation causes renal osteodystrophy
• Both osteoclastic resorption AND osteoblast activation occur, but with pathological coupling

Summary Table